BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9720755)

  • 1. FLT3: receptor and ligand. Biology and potential clinical application.
    Shurin MR; Esche C; Lotze MT
    Cytokine Growth Factor Rev; 1998 Mar; 9(1):37-48. PubMed ID: 9720755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis.
    Namikawa R; Muench MO; Roncarolo MG
    Stem Cells; 1996 Jul; 14(4):388-95. PubMed ID: 8843540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.
    Piacibello W; Garetto L; Sanavio F; Severino A; Fubini L; Stacchini A; Dragonetti G; Aglietta M
    Exp Hematol; 1996 Feb; 24(2):340-6. PubMed ID: 8641363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
    J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
    Lyman SD; Brasel K; Rousseau AM; Williams DE
    Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic effects of flt3 ligand in vivo in mice.
    Brasel K; McKenna HJ; Morrissey PJ; Charrier K; Morris AE; Lee CC; Williams DE; Lyman SD
    Blood; 1996 Sep; 88(6):2004-12. PubMed ID: 8822919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flt3 ligand bioactivity and pharmacology in neoplasia.
    Reber AJ; Ashour AE; Robinson SN; Talmadge JE; Solheim JC
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):149-56. PubMed ID: 15180455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of flt3 ligand and receptor.
    Lyman SD
    Int J Hematol; 1995 Aug; 62(2):63-73. PubMed ID: 8590775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.
    Hjertson M; Sundström C; Lyman SD; Nilsson K; Nilsson G
    Exp Hematol; 1996 May; 24(6):748-54. PubMed ID: 8635531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.
    Ogawa M; Sugawara S; Kunisada T; Sudo T; Hayashi S; Nishikawa S; Kodama H; Nishikawa S
    Exp Hematol; 1998 Jun; 26(6):478-88. PubMed ID: 9620281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD135 (Flk2/Flt3) expression by human thymocytes delineates a possible role of FLT3-ligand in T-cell precursor proliferation and differentiation.
    Bertho JM; Chapel A; Loilleux S; Frick J; Aigueperse J; Gorin NC; Gourmelon P
    Scand J Immunol; 2000 Jul; 52(1):53-61. PubMed ID: 10886784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit.
    Jin L; Neff T; Blau CA
    Exp Hematol; 1999 Mar; 27(3):520-5. PubMed ID: 10089915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
    Rossner MT; McArthur GA; Allen JD; Metcalf D
    Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLT3: receptor and ligand.
    Drexler HG; Quentmeier H
    Growth Factors; 2004 Jun; 22(2):71-3. PubMed ID: 15253381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of haematopoietic progenitor development by FLT-3 ligand.
    Banu N; Deng B; Lyman SD; Avraham H
    Cytokine; 1999 Sep; 11(9):679-88. PubMed ID: 10479404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation.
    Rasko JE; Metcalf D; Rossner MT; Begley CG; Nicola NA
    Leukemia; 1995 Dec; 9(12):2058-66. PubMed ID: 8609717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors.
    Hunte BE; Hudak S; Campbell D; Xu Y; Rennick D
    J Immunol; 1996 Jan; 156(2):489-96. PubMed ID: 8543798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and signal transduction of the FLT3 tyrosine kinase receptor.
    Rosnet O; Bühring HJ; deLapeyrière O; Beslu N; Lavagna C; Marchetto S; Rappold I; Drexler HG; Birg F; Rottapel R; Hannum C; Dubreuil P; Birnbaum D
    Acta Haematol; 1996; 95(3-4):218-23. PubMed ID: 8677746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells.
    Drexler HG; Meyer C; Quentmeier H
    Leuk Lymphoma; 1999 Mar; 33(1-2):83-91. PubMed ID: 10194124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.